Greg Boss, Executive Vice President Legal and Group Counsel, CSL

Robert R. Baron, Jr.

Stuart Langbein, Partner, Hogan Lovells US LLP

Kevin Arquit, Partner, Simpson Thacher & Bartlett LLP

Jeff Barker, Executive Directors, Cushman & Wakefield

Jack Friedman (Moderator), Chairman, Directors Roundtable

General counsel are more important than ever in history. Boards of Directors increasingly look to them to enhance financial and business strategy, compliance, and integrity of corporate operations. Please join us to recognize Greg Boss, Group General Counsel of CSL Limited, with the leading global honor for general counsel in recognition of his professional accomplishments and passion for ethical leadership. CSL is a leading global biopharmaceutical and specialty biotherapeutics company headquartered in Australia with major operations in the United States. It has more than 16,000 employees conducting business in over 30 countries. CSL marks its 100th anniversary in 2016.

Mr. Boss will address key challenges facing the General Counsel of an international pharmaceutical business and discuss how he and his team help the company deliver on its promises to patients, partners, and shareholders in an ever-changing global economy. Panelists will discuss intellectual property, government regulations including FDA and Medicare, risk management, antitrust, and operating a national system of plasma collection centers.

There is no fee to attend and continental breakfast will be served.

The transcript of this event will be made available worldwide in electronic copy.

This program is approved for 2.0 PA, NY, and CA CLE credits. Uniform Certificates of Attendance will also be made available for the purpose of seeking credit in other jurisdictions.

For more information or to register click here; you may also contact Karen Todd, The Directors Roundtable, 727.493.2067.